Info For Sponsors - Our Staff - Deborah R. Tunick, RN

CURRICULUM VITAE

EDUCATION:
2001     Undergraduate:     Abilene Christian University
Abilene, Texas
Bachelor of Science in Nursing
Minor in Child Psychology
2001     Nursing School:     Abilene Intercollegiate School of Nursing
Abilene, Texas
Registered Nurse
WORK EXPERIENCE:
2004- present     Research Coordinator/Site Manager
Chesapeake Research Group, LLC
Pasadena, Maryland
2003- 2004     Clinical Research Nurse
Scirex
Cockeysville, Maryland
2001- 2003     Staff Registered Nurse on Oncology/Surgical Unit
Anne Arundel Medical Center
Annapolis, Maryland
CLINICAL TRIAL EXPERIENCE:

J&JPRD R331333PAI3003 (2007)
Study Coordinator

Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Multiple Doses of CG5503 Immediate-Release Formulation in the Treatment of Acute Pain From Bunionectomy Followed by a Voluntary Open-Label Extension.

QRx Pharma Q8003-007/010
Study Coordinator

Q8003-007-A Placebo-Controlled, Randomized, Double-Blind Study of the Safely and Efficacy of Q8003 in the Management of Post-Bunionectomy Pain.
Q8003-010-A Double-Blind, Multi-Center Extension Study to Evaluate the Safety and Efficacy of Q8003 in Patients with Acute Moderate to Severe Pain.

ABBO2814 M05-790 (2006)
Study Coordinator

A Phase 3, Open-Label Period Followed by a Randomized, Double-Blind, Placebo-Controlled Study of the Analgesic Efficacy and Safety of (the study drug) Compared to Placebo in Subjects with Chronic Low Back Pain

ABBO2814 M04-697 (2006)
Study Coordinator

A Phase 3, Randomized, Multicenter, Double-Blind Study Comparing the Analgesic Efficacy of (the study drug) to Placebo in Subjects With Osteoarthritis.

Hisamitsu HKT-500-US05 (2005)
Study Coordinator

A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Two-Week Study to Assess the Safety and Efficacy of HKT-500 in Subjects with pain from Moderate Lateral Epicondylitis.

GSK SB767905/014 (2005)
Study Coordinator

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Long-Term Safety of (the study drug) for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults taking Opioid Therapy for Persistent Non-Cancer Pain.

Hisamitsu HKT-500-US06 (2005)
Study Coordinator

An Open Label Safety Study with Intermittent Use of HKT-500 in Subjects with Lower Back Pain, Pain from Osteoarthritis of the Knee, Shoulder Pain or Lateral Epicondylitis Pain.

ABBO2814 M03-666 (2005)
Study Coordinator

An Open Label Study Evaluating the Safety and Tolerability of Long Term Administration of (the study drug) in Subjects with Moderate to Severe Chronic Non-Malignant Pain.

Guilford Pharmaceuticals 3000-0412 (2004)
Study Coordinator

A Phase III, Randomized, Open Label Study to Assess the Safety and Efficacy of (Study drug) Versus Midazolam HCL for Sedation in Patients Undergoing Minor Surgical Procedures.

ABBO2814 M03-643 (2004)
Study Coordinator

A Randomized, Multi-Center, Double-Blind Study Comparing the Analgesic Efficacy of (Study drug) Extended Release and Placebo in Subjects with Osteoarthritis.

AlgoRx Pharmaceuticals, Inc. 4975-2-003-1 (2004)
Study Coordinator

Randomized, Double-Blind, Placebo-Controlled Dose Ranging Trial of (Study drug) in Subjects Undergoing Bunionectomy with First Metatarsal Osteotomy Surgery.

Metaphore Pharmaceuticals U10-03-02-005 (2003)
A double-blind, randomized comparison of the analgesic activity of M40403 + Morphine versus morphine alone in a post-surgical dental pain mode.

ABBO2814 M03-609 (2003)
A Randomized, Double-Blind, Placebo-Controlled Study Comparing the Analgesic Activity of (Study drug) Extended Release and Placebo in Subjects with Pain Following Bunionectomy Surgery.

For further information contact info@crgmd.com